Drug/Insect/Latex News

ATLANTA — A two-year extension of the VIPES trial involving Viaskin Peanut showed that more than 80% of children using the skin patch could tolerate more peanut protein, according to findings presented at the annual meeting of the American Academy of Allergy, Asthma and Immunology.

ATLANTA — Walnut oral immunotherapy effectively induced walnut desensitization, as well as cross-desensitization to a secondary tree nut, in a majority of tree nut-allergic patients, according to early data presented at the annual meeting of the American Academy of Allergy, Asthma & Immunology.

ATLANTA — Parents who alternate between formula feeding, pumping milk and breastfeeding their children within the first 6 months of the child’s life may be putting their children at risk for food allergy symptoms compared to those children exclusively breastfed, according to findings presented at the annual meeting of the American Academy of Allergy, Asthma and Immunology.

The FDA has approved Odactra, the first allergen extract to be administered sublingually to treat allergic rhinitis with or without conjunctivitis induced by house dust mites, in people aged 18 through 65 years, according to a recent press release.

An elemental diet reduced eosinophilic inflammation, improved symptoms and induced clinical remission in adults with eosinophilic esophagitis, according to prospective study data.

The National Institute of Allergy and Infectious Diseases has published addendum guidelines along with findings from the LEAP study that demonstrate that introducing peanut-containing foods early may reduce the risk for allergy.

The epinephrine auto-injector AUVI-Q, used for the emergency treatment of anaphylaxis, will be available starting Feb. 14, kaléo, its manufacturer, said today.

Compared with allergists, primary care providers ordered significantly more food allergen panels and generated higher cost per patient, according to recent study findings.

Children were able to overcome allergic response to peanuts by wearing a skin patch that administered epicutaneous immunotherapy in the form of peanut protein, according to clinical trial findings published in the Journal of Allergy and Clinical Immunology.

Decreased lung function and increased asthma symptoms in children were associated with elevated levels of mouse allergen in urban elementary and middle schools, according to a recently published study.